Protagonist Therapeutics Inc (PTGX)
39.25
-1.35
(-3.33%)
USD |
NASDAQ |
Dec 24, 13:00
39.30
+0.05
(+0.13%)
After-Hours: 13:22
Protagonist Therapeutics Free Cash Flow: 229.23M for Sept. 30, 2024
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Assembly Biosciences Inc | 22.84M |
| Precision BioSciences Inc | -48.36M |
| Entrada Therapeutics Inc | -17.46M |
| NovaBay Pharmaceuticals Inc | -4.812M |
| Palatin Technologies Inc | -32.57M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -27.86M |
| Cash from Investing (Quarterly) | -208.71M |
| Cash from Financing (Quarterly) | 12.05M |
| Free Cash Flow Per Share (Quarterly) | -0.4636 |
| Free Cash Flow to Equity (Quarterly) | -28.64M |
| Free Cash Flow to Firm (Quarterly) | -28.64M |
| Free Cash Flow Yield | 9.45% |